N.M. Stat. § 26-1-12 (2026)

A. An advertisement of a drug, device or cosmetic shall be deemed to be false if it is
false or misleading in any particular.

    B. For the purpose of the New Mexico Drug and Cosmetic Act [New Mexico Drug,
Device and Cosmetic Act] the advertisement of a drug or device representing it to have
any effect in albuminuria, appendicitis, arteriosclerosis, blood poison, bone disease,
Bright's disease, cancer, carbuncles, cholecystitis, diabetes, diphtheria, dropsy,
erysipelas, gallstones, heart and vascular diseases, high blood pressure, mastoiditis,
measles, meningitis, mumps, nephritis, otitis media, paralysis, pneumonia, poliomyelitis
(infantile paralysis), prostate gland disorders, pyelitis, scarlet fever, sexual impotence,
sinus infection, small pox [smallpox], tuberculosis, tumors, typhoid, uremia, veneral
[venereal] disease, shall also be deemed to be false, except that no advertisement not
in violation of Subsection A shall be deemed to be false under this subsection if it is
disseminated only to members of the pharmacy, medical, dental or veterinary
profession or appears only in the scientific periodicals of those professions or is
disseminated only for the purpose of public health education by persons not
commercially interested, directly or indirectly, in the sale of such drugs or devices;
provided, that whenever the board determines that an advance in medical science has
made any type of self-medication safe as to any of the diseases named above, [the]
board shall by regulation authorize the advertisement of drugs having curative or
therapeutic effect for such disease, subject to such conditions and restrictions as the
board may deem necessary in the interests of public health; provided, that this
subsection shall not be construed as indicating that self-medication for diseases other
than those named herein is safe or efficacious.

    C. In the case of any dangerous drug distributed or offered for sale in this state by a
manufacturer, packer, distributor or retailer, all advertisement with respect to that drug
shall contain a true statement of the established or official name, together with any trade
or brand name; the formula as represented on the label, in the same order of listing and
with all listed warnings and cautions; the dosage form and strength; such other
information in brief summary relating to its use, side effects, contraindications and the
name of the manufacturer, packer or distributor; provided, that no advertisement
prepared in accordance with Section 502(n) of the federal act and disseminated only to
practitioners and dispensers shall be in violation of this subsection.

History: 1953 Comp., § 54-6-37, enacted by Laws 1967, ch. 23, § 12.

                                     ANNOTATIONS

Bracketed material. — The bracketed material was inserted by the compiler and is not
part of the law.
Laws 1987, ch. 270, § 8 provided that references to the New Mexico Drug and
Cosmetic Act shall be construed as references to the New Mexico Drug, Device and
Cosmetic Act.

Cross references. — For definition of "advertisement", see 26-1-2 Q NMSA 1978.

For the definition of "federal act", see 26-1-2W NMSA 1978.